Edgewise Therapeutics, Inc. SEC filings EWTX
Edgewise Therapeutics, Inc. has 421 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2022 | — |
| EFFECT | Filing | Mar 25, 2021 | — |
| CERT | Filing | Mar 25, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| 8-A12B | Filing | Mar 17, 2021 | — |
| CORRESP | Letter to the SEC | Mar 8, 2021 | — |
| DRS/A | Filing | Mar 2, 2021 | — |
| DRS/A | Filing | Jan 25, 2021 | — |
| DRSLTR | Filing | Jan 22, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2021 | — |
| DRS | Filing | Dec 18, 2020 | — |
| D | Filing | Dec 10, 2020 | — |
| D | Filing | Sep 26, 2019 | — |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710072
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.